Disseminated Intravascular Coagulation (DIC) Market Size Forecasted To Achieve 0.59 Billion By 2029 With Steady Growth

We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

What Is the Disseminated Intravascular Coagulation (DIC) Market Size and Projected Growth Rate?
In recent years, the market size for disseminated intravascular coagulation (DIC) has witnessed significant growth. The market is projected to expand from $0.46 billion in 2024 to $0.49 billion in 2025, with an impressive compound annual growth rate (CAGR) of 5.3%. The surge in this historical period can be credited to factors such as the increasing occurrence of sepsis, a rise in trauma instances, growing rates of cancer, elevated healthcare expenditure, improved consciousness among medical professionals, and an inclination towards the acceptance of targeted therapies.

Expectations are high for the disseminated intravascular coagulation (DIC) market as it's predicted to witness robust growth in the coming years. The market valuation is anticipated to reach $0.59 billion in 2029 with a compound annual growth rate (CAGR) of 5.0%. Factors contributing to such growth in the forecasted period may include increased use of targeted therapies, a more concentrated effort towards early disease detection, greater investments in healthcare facilities, expanded clinical research around coagulopathy treatments, and a heightened understanding of seldom-seen hematological conditions. Upcoming trends within this period could involve enhancements in diagnostic assays, the utilization of innovation in anticoagulant therapies, the rise of personalized medicine, AI incorporation in diagnostics, advancements in patient monitoring gadgets, and the creation of focused treatments.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21172

What Are the Major Segments in the Disseminated Intravascular Coagulation (DIC) Market?
The disseminated intravascular coagulation (DIC) market covered in this report is segmented -

1) By Treatment: Medicines, Transfusions, Surgery, Other Treatments
2) By Diagnosis: Complete Blood Count With Blood Smear Exam, Partial Thromboplastin Time (PTT), Fibrinogen Blood Test, D-dimer, Other Diagnoses
3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:
1) By Medicines: Anticoagulants, Antiplatelet Drugs, Fibrinolytics, Procoagulants, Antithrombin Therapy
2) By Transfusions: Platelet Transfusion, Fresh Frozen Plasma (FFP), Cryoprecipitate Transfusion, Red Blood Cell Transfusion
3) By Surgery: Surgical Removal Of Thrombus, Organ Surgery
4) By Other Treatments: Plasma Exchange, Supportive Care, Steroid Therapy

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21172&type=smp

What Are The Driving Disseminated Intravascular Coagulation (DIC) Market Evolution?
The rise in cancer incidence is anticipated to fuel the dissemination of the intravascular coagulation (DIC) market in the future. Cancer is an illness distinguished by the uncontrolled proliferation and diffusion of irregular cells in the body, resulting in the invasion and destruction of regular tissues. The growing number of cancer cases is due to factors such as an aging population, changes in lifestyle, environmental exposure, infections, and genetic susceptibility. Cancer can instigate disseminated intravascular coagulation (DIC) by causing excessive activation of the coagulation cascade using tumor-produced procoagulant substances, resulting in widespread clotting and bleeding. For example, the National Cancer Institute, a government agency in the US, reported in May 2024 that around 20 million new cancer cases and 9.7 million cancer-related deaths were registered globally in 2022. These figures are projected to rise to 29.9 million fresh cases and 15.3 million deaths annually by 2040. As a result, the escalating incidence of cancer is propelling the growth of the disseminated intravascular coagulation (DIC) market.

Which Firms Dominate The Disseminated Intravascular Coagulation (DIC) Market Segments?
Major companies operating in the disseminated intravascular coagulation (DIC) market are Nihon Kohden Corporation, Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., AbbVie Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, Thermo Fisher Scientific Inc., Fresenius Kabi AG, GlaxoSmithKline plc, Danaher Corporation, Eli Lily and Company, Siemens Healthineers, Teva Pharmaceutical Industries Ltd., Mylan N.V., Grifols S.A., Eisai Co. Ltd., Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc.

What Trends Are Expected to Dominate the Disseminated Intravascular Coagulation (DIC) Market in the Next 5 Years?
Leading businesses in the disseminated intravascular coagulation (DIC) market are concentrating on improvements in coagulation diagnostic technologies such as next-generation blood clotting examinations. These advancements intend to increase diagnostic precision, speed, and convenience, leading to earlier interventions and better patient results. Next-generation blood clotting tests are advanced diagnostic methods intended to evaluate blood coagulation more accurately, efficiently, and comprehensively than conventional tests. For example, LumiraDx Limited, a health company based in the UK, broadened its cardiovascular testing range in June 2022, receiving CE Mark approvals for its NT-proBNP and updated D-Dimer tests. These examinations enhance the LumiraDx Platform's ability to assist medical professionals in diagnosing heart failure and excluding venous thromboembolism at the point of care. The advancements target the improvement of early detection and treatment of cardiovascular and thrombotic conditions, including DIC.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/disseminated-intravascular-coagulation-dic-global-market-report

Which Is The Largest Region In The Disseminated Intravascular Coagulation (DIC) Market?
North America was the largest region in the disseminated intravascular coagulation (DIC) market in 2024. The regions covered in the disseminated intravascular coagulation (DIC) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Disseminated Intravascular Coagulation (DIC) Market?
2. What is the CAGR expected in the Disseminated Intravascular Coagulation (DIC) Market?
3. What Are the Key Innovations Transforming the Disseminated Intravascular Coagulation (DIC) Industry?
4. Which Region Is Leading the Disseminated Intravascular Coagulation (DIC) Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.